Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Kemp

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of Shoulder and Elbow Surgery|January 19, 2016
The long-term outcome of the Gschwend-Scheier-Bähler III elbow replacementEwan Bigsby, Mark Kemp, Nashat Siddiqui, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 24, 2009
Modulation of the partition coefficient between octanol and buffer at pH 7.4 and pKa to achieve the optimum balance of blood clearance and volume of distribution for a series of tetrahydropyran histamine type 3 receptor antagonistsTanya Hay, Rhys Jones, Kevin Beaumont, et al.
Cell Biochemistry and Biophysics|May 29, 2013
Deubiquitylating enzymes and DNA damage response pathwaysXavier Jacq, Mark Kemp, Niall M B Martin, et al.
The Journal of Foot and Ankle Surgery : Official Publication of the American College of Foot and Ankle Surgeons|May 6, 2014
Complications after revision surgery of malreduced ankle fracturesEwan Bigsby, Simon Cowie, Rory G Middleton, et al.
British Journal of Pharmacology|September 27, 2005
Subtype-specific actions of beta-amyloid peptides on recombinant human neuronal nicotinic acetylcholine receptors (alpha7, alpha4beta2, alpha3beta4) expressed in Xenopus laevis oocytesLuanda Pym, Mark Kemp, Valérie Raymond-Delpech, et al.
Bioorganic & Medicinal Chemistry|December 13, 2018
The discovery and optimization of benzimidazoles as selective Na<sub>V</sub>1.8 blockers for the treatment of painAlan D Brown, Sharan K Bagal, Paul Blackwell, et al.
Nature Communications|November 13, 2023
Knockout or inhibition of USP30 protects dopaminergic neurons in a Parkinson's disease mouse modelTracy-Shi Zhang Fang, Yu Sun, Andrew C Pearce, et al.
British Journal of Pharmacology|January 28, 2015
A novel selective and orally bioavailable Nav 1.8 channel blocker, PF-01247324, attenuates nociception and sensory neuron excitabilityClaire Elizabeth Payne, Adam R Brown, Jonathon W Theile, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of Shoulder and Elbow Surgery|January 19, 2016
The long-term outcome of the Gschwend-Scheier-Bähler III elbow replacementEwan Bigsby, Mark Kemp, Nashat Siddiqui, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 24, 2009
Modulation of the partition coefficient between octanol and buffer at pH 7.4 and pKa to achieve the optimum balance of blood clearance and volume of distribution for a series of tetrahydropyran histamine type 3 receptor antagonistsTanya Hay, Rhys Jones, Kevin Beaumont, et al.
Cell Biochemistry and Biophysics|May 29, 2013
Deubiquitylating enzymes and DNA damage response pathwaysXavier Jacq, Mark Kemp, Niall M B Martin, et al.
The Journal of Foot and Ankle Surgery : Official Publication of the American College of Foot and Ankle Surgeons|May 6, 2014
Complications after revision surgery of malreduced ankle fracturesEwan Bigsby, Simon Cowie, Rory G Middleton, et al.
British Journal of Pharmacology|September 27, 2005
Subtype-specific actions of beta-amyloid peptides on recombinant human neuronal nicotinic acetylcholine receptors (alpha7, alpha4beta2, alpha3beta4) expressed in Xenopus laevis oocytesLuanda Pym, Mark Kemp, Valérie Raymond-Delpech, et al.
Bioorganic & Medicinal Chemistry|December 13, 2018
The discovery and optimization of benzimidazoles as selective Na<sub>V</sub>1.8 blockers for the treatment of painAlan D Brown, Sharan K Bagal, Paul Blackwell, et al.
Nature Communications|November 13, 2023
Knockout or inhibition of USP30 protects dopaminergic neurons in a Parkinson's disease mouse modelTracy-Shi Zhang Fang, Yu Sun, Andrew C Pearce, et al.
British Journal of Pharmacology|January 28, 2015
A novel selective and orally bioavailable Nav 1.8 channel blocker, PF-01247324, attenuates nociception and sensory neuron excitabilityClaire Elizabeth Payne, Adam R Brown, Jonathon W Theile, et al.
Pageof 1